Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Identification of differentially expressed circular RNAs in chemoresistant colorectal cancer.

Abu N, Hon KW, Jeyaraman S, Yahaya A, Abdullah NM, Mustangin M, Sulaiman SA, Jamal R, Ab-Mutalib NS.

Epigenomics. 2019 Jun;11(8):875-884. doi: 10.2217/epi-2019-0042. Epub 2019 Apr 25.

PMID:
31020847
2.

Maternal and neonatal effects of Acinetobacter colonisation in preterm premature rupture of membrane and term labour.

Sood M, Mohd Zain Z, Abu NA, Chee SC, Mohd Nor NS.

Med J Malaysia. 2019 Feb;74(1):40-44.

3.

In vitro and in vivo antitumour effects of coconut water vinegar on 4T1 breast cancer cells.

Mohamad NE, Yeap SK, Abu N, Lim KL, Zamberi NR, Nordin N, Sharifuddin SA, Long K, Alitheen NB.

Food Nutr Res. 2019 Jan 10;63. doi: 10.29219/fnr.v63.1616. eCollection 2019.

4.

In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.

Nordin N, Yeap SK, Rahman HS, Zamberi NR, Abu N, Mohamad NE, How CW, Masarudin MJ, Abdullah R, Alitheen NB.

Sci Rep. 2019 Feb 7;9(1):1614. doi: 10.1038/s41598-018-38214-x.

5.

Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis.

Razak NA, Abu N, Ho WY, Zamberi NR, Tan SW, Alitheen NB, Long K, Yeap SK.

Sci Rep. 2019 Feb 6;9(1):1514. doi: 10.1038/s41598-018-37796-w.

6.

Long noncoding RNAs as biotargets in cisplatin-based drug resistance.

Abu N, Hon KW, Jeyaraman S, Jamal R.

Future Oncol. 2018 Dec;14(29):3085-3095. doi: 10.2217/fon-2018-0303. Epub 2018 Nov 23. Review.

PMID:
30468082
7.

The Interplay Between Tobacco Dependence and Sleep Quality Among Young Adults.

Cohen A, Ben Abu N, Haimov I.

Behav Sleep Med. 2018 Nov 21:1-14. doi: 10.1080/15402002.2018.1546707. [Epub ahead of print]

PMID:
30463440
8.

Prospective Advances in Circular RNA Investigation.

Sulaiman SA, Abdul Murad NA, Mohamad Hanif EA, Abu N, Jamal R.

Adv Exp Med Biol. 2018;1087:357-370. doi: 10.1007/978-981-13-1426-1_28. Review.

PMID:
30259380
9.

The potential immune-eliciting cancer testis antigens in colorectal cancer.

Chi Soh JE, Abu N, Jamal R.

Immunotherapy. 2018 Sep;10(12):1093-1104. doi: 10.2217/imt-2018-0044.

PMID:
30185136
10.

miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer.

Hon KW, Abu N, Ab Mutalib NS, Jamal R.

Front Pharmacol. 2018 Aug 6;9:846. doi: 10.3389/fphar.2018.00846. eCollection 2018. Review.

11.

Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer.

Suhaimi SS, Ab Mutalib NS, Khor SS, Zain RRM, Syafruddin SE, Abu N, Mohd Dali AZH, Jamal R.

Front Pharmacol. 2018 Jul 13;9:750. doi: 10.3389/fphar.2018.00750. eCollection 2018.

12.

The taste of KCl - What a difference a sugar makes.

Ben Abu N, Harries D, Voet H, Niv MY.

Food Chem. 2018 Jul 30;255:165-173. doi: 10.1016/j.foodchem.2018.01.175. Epub 2018 Feb 1.

PMID:
29571463
13.

Subchronic toxicity, immunoregulation and anti-breast tumor effect of Nordamnacantal, an anthraquinone extracted from the stems of Morinda citrifolia L.

Abu N, Zamberi NR, Yeap SK, Nordin N, Mohamad NE, Romli MF, Rasol NE, Subramani T, Ismail NH, Alitheen NB.

BMC Complement Altern Med. 2018 Jan 27;18(1):31. doi: 10.1186/s12906-018-2102-3.

14.

Characterization and toxicity of citral incorporated with nanostructured lipid carrier.

Nordin N, Yeap SK, Zamberi NR, Abu N, Mohamad NE, Rahman HS, How CW, Masarudin MJ, Abdullah R, Alitheen NB.

PeerJ. 2018 Jan 4;6:e3916. doi: 10.7717/peerj.3916. eCollection 2018.

15.

Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway.

Aziz MNM, Hussin Y, Che Rahim NF, Nordin N, Mohamad NE, Yeap SK, Yong CY, Masarudin MJ, Cheah YK, Abu N, Akhtar MN, Alitheen NB.

Molecules. 2018 Jan 5;23(1). pii: E75. doi: 10.3390/molecules23010075.

16.

LOC285629 regulates cell proliferation and motility in colorectal cancer cells.

Nasir SN, Abu N, Ab Mutalib NS, Ishak M, Sagap I, Mazlan L, Rose IM, Jamal R.

Clin Transl Oncol. 2018 Jun;20(6):775-784. doi: 10.1007/s12094-017-1788-x. Epub 2017 Nov 2.

PMID:
29098557
17.

Bitter or not? BitterPredict, a tool for predicting taste from chemical structure.

Dagan-Wiener A, Nissim I, Ben Abu N, Borgonovo G, Bassoli A, Niv MY.

Sci Rep. 2017 Sep 21;7(1):12074. doi: 10.1038/s41598-017-12359-7.

18.

Exosomes As Potential Biomarkers and Targeted Therapy in Colorectal Cancer: A Mini-Review.

Hon KW, Abu N, Ab Mutalib NS, Jamal R.

Front Pharmacol. 2017 Aug 28;8:583. doi: 10.3389/fphar.2017.00583. eCollection 2017. Review.

19.

Histological analysis of anti-cancer drug loaded, targeted Mn:ZnS quantum dots in metastatic lesions of 4T1 challenged mice.

Birma Bwatanglang I, Mohammad F, Yusof NA, Elyani Mohammed N, Abu N, Alitheen NB, Abdullah J, Zubir Hussein M, Abba Y, Nordin N, Rizi Zamberi N.

J Mater Sci Mater Med. 2017 Aug 8;28(9):138. doi: 10.1007/s10856-017-5949-9.

PMID:
28791524
20.

Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing.

Abdul SN, Ab Mutalib NS, Sean KS, Syafruddin SE, Ishak M, Sagap I, Mazlan L, Rose IM, Abu N, Mokhtar NM, Jamal R.

Front Pharmacol. 2017 Jul 18;8:465. doi: 10.3389/fphar.2017.00465. eCollection 2017.

21.

Characterisation of sol-gel method synthesised MgZnFe2O4 nanoparticles and its cytotoxic effects on breast cancer cell line, MDA MB-231 in vitro.

Nordin N, Kanagesan S, Zamberi NR, Yeap SK, Abu N, Tamilselvan S, Hashim M, Alitheen NB.

IET Nanobiotechnol. 2017 Apr;11(3):343-348. doi: 10.1049/iet-nbt.2016.0007.

PMID:
28476993
22.

Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells.

Ali NM, Yeap SK, Abu N, Lim KL, Ky H, Pauzi AZM, Ho WY, Tan SW, Alan-Ong HK, Zareen S, Alitheen NB, Akhtar MN.

Cancer Cell Int. 2017 Feb 21;17:30. doi: 10.1186/s12935-017-0400-3. eCollection 2017.

23.

Seagrass ecosystems reduce exposure to bacterial pathogens of humans, fishes, and invertebrates.

Lamb JB, van de Water JA, Bourne DG, Altier C, Hein MY, Fiorenza EA, Abu N, Jompa J, Harvell CD.

Science. 2017 Feb 17;355(6326):731-733. doi: 10.1126/science.aal1956.

PMID:
28209895
24.

Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro.

Pauzi AZ, Yeap SK, Abu N, Lim KL, Omar AR, Aziz SA, Chow AL, Subramani T, Tan SG, Alitheen NB.

Chin Med. 2016 Nov 15;11:46. eCollection 2016.

25.

Combinatorial Cytotoxic Effects of Damnacanthal and Doxorubicin against Human Breast Cancer MCF-7 Cells in Vitro.

Aziz MY, Abu N, Yeap SK, Ho WY, Omar AR, Ismail NH, Ahmad S, Pirozyan MR, Akhtar NM, Alitheen NB.

Molecules. 2016 Sep 14;21(9). pii: E1228. doi: 10.3390/molecules21091228.

26.

Circular RNAs as Promising Biomarkers: A Mini-Review.

Abu N, Jamal R.

Front Physiol. 2016 Aug 18;7:355. doi: 10.3389/fphys.2016.00355. eCollection 2016. Review.

27.

Efficient Double Suzuki Cross-Coupling Reactions of 2,5-Dibromo-3-hexylthiophene: Anti-Tumor, Haemolytic, Anti-Thrombolytic and Biofilm Inhibition Studies.

Ikram HM, Rasool N, Zubair M, Khan KM, Abbas Chotana G, Akhtar MN, Abu N, Alitheen NB, Elgorban AM, Rana UA.

Molecules. 2016 Jul 27;21(8). pii: E977. doi: 10.3390/molecules21080977.

28.

Gene Expression Analysis Reveals the Concurrent Activation of Proapoptotic and Antioxidant-Defensive Mechanisms in Flavokawain B-Treated Cervical Cancer HeLa Cells.

Yeap SK, Abu N, Akthar N, Ho WY, Ky H, Tan SW, Alitheen NB, Kamarul T.

Integr Cancer Ther. 2017 Sep;16(3):373-384. doi: 10.1177/1534735416660383. Epub 2016 Jul 24.

29.

In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.

Bwatanglang IB, Mohammad F, Yusof NA, Abdullah J, Alitheen NB, Hussein MZ, Abu N, Mohammed NE, Nordin N, Zamberi NR, Yeap SK.

J Colloid Interface Sci. 2016 Oct 15;480:146-158. doi: 10.1016/j.jcis.2016.07.011. Epub 2016 Jul 7.

PMID:
27428851
30.

Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.

Ali NM, Akhtar MN, Ky H, Lim KL, Abu N, Zareen S, Ho WY, Alan-Ong HK, Tan SW, Alitheen NB, Ismail JB, Yeap SK, Kamarul T.

Drug Des Devel Ther. 2016 Jun 10;10:1897-907. doi: 10.2147/DDDT.S102164. eCollection 2016.

31.

The Growth Inhibitory Potential and Antimetastatic Effect of Camel Urine on Breast Cancer Cells In Vitro and In Vivo.

Romli F, Abu N, Khorshid FA, Syed Najmuddin SUF, Keong YS, Mohamad NE, Hamid M, Alitheen NB, Nik Abd Rahman NMA.

Integr Cancer Ther. 2017 Dec;16(4):540-555. doi: 10.1177/1534735416656051. Epub 2016 Jun 23.

32.

The Antimetastatic and Antiangiogenesis Effects of Kefir Water on Murine Breast Cancer Cells.

Zamberi NR, Abu N, Mohamed NE, Nordin N, Keong YS, Beh BK, Zakaria ZA, Nik Abdul Rahman NM, Alitheen NB.

Integr Cancer Ther. 2016 Dec;15(4):NP53-NP66. Epub 2016 May 26.

33.

Dual Regulation of Cell Death and Cell Survival upon Induction of Cellular Stress by Isopimara-7,15-Dien-19-Oic Acid in Cervical Cancer, HeLa Cells In vitro.

Abu N, Yeap SK, Pauzi AZ, Akhtar MN, Zamberi NR, Ismail J, Zareen S, Alitheen NB.

Front Pharmacol. 2016 Mar 31;7:89. doi: 10.3389/fphar.2016.00089. eCollection 2016.

34.

Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.

Abu N, Akhtar MN, Yeap SK, Lim KL, Ho WY, Abdullah MP, Ho CL, Omar AR, Ismail J, Alitheen NB.

BMC Complement Altern Med. 2016 Feb 27;16:86. doi: 10.1186/s12906-016-1046-8.

35.

Folic acid targeted Mn:ZnS quantum dots for theranostic applications of cancer cell imaging and therapy.

Bwatanglang IB, Mohammad F, Yusof NA, Abdullah J, Hussein MZ, Alitheen NB, Abu N.

Int J Nanomedicine. 2016 Jan 22;11:413-28. doi: 10.2147/IJN.S90198. eCollection 2016.

36.

In vitro Toxicity and in vivo Immunomodulatory Effects of Flavokawain A and Flavokawain B in Balb/C Mice.

Abu N, Mohameda NE, Tangarajoo N, Yeap SK, Akhtar MN, Abdullah MP, Omar AR, Alitheen NB.

Nat Prod Commun. 2015 Jul;10(7):1199-202.

PMID:
26411010
37.

Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice.

Yeap SK, Abu N, Mohamad NE, Beh BK, Ho WY, Ebrahimi S, Yusof HM, Ky H, Tan SW, Alitheen NB.

BMC Complement Altern Med. 2015 Sep 4;15:306. doi: 10.1186/s12906-015-0832-z.

38.

In Vivo Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice.

Abu N, Mohamed NE, Yeap SK, Lim KL, Akhtar MN, Zulfadli AJ, Kee BB, Abdullah MP, Omar AR, Alitheen NB.

Anticancer Agents Med Chem. 2015;15(7):905-15.

PMID:
26179368
39.

A novel psychovisual threshold on large DCT for image compression.

Abu NA, Ernawan F.

ScientificWorldJournal. 2015;2015:821497. doi: 10.1155/2015/821497. Epub 2015 Mar 22.

40.

In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.

Abu N, Mohamed NE, Yeap SK, Lim KL, Akhtar MN, Zulfadli AJ, Kee BB, Abdullah MP, Omar AR, Alitheen NB.

Drug Des Devel Ther. 2015 Mar 6;9:1401-17. doi: 10.2147/DDDT.S67976. eCollection 2015.

41.

Synthesis of an anthraquinone derivative (DHAQC) and its effect on induction of G2/M arrest and apoptosis in breast cancer MCF-7 cell line.

Yeap S, Akhtar MN, Lim KL, Abu N, Ho WY, Zareen S, Roohani K, Ky H, Tan SW, Lajis N, Alitheen NB.

Drug Des Devel Ther. 2015 Feb 17;9:983-92. doi: 10.2147/DDDT.S65468. eCollection 2015.

42.

Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro.

Abu N, Akhtar MN, Yeap SK, Lim KL, Ho WY, Zulfadli AJ, Omar AR, Sulaiman MR, Abdullah MP, Alitheen NB.

PLoS One. 2014 Oct 6;9(10):e105244. doi: 10.1371/journal.pone.0105244. eCollection 2014.

43.

In vitro characterization and mechanical properties of β-calcium silicate/POC composite as a bone fixation device.

Shirazi FS, Moghaddam E, Mehrali M, Oshkour AA, Metselaar HS, Kadri NA, Zandi K, Abu NA.

J Biomed Mater Res A. 2014 Nov;102(11):3973-85. doi: 10.1002/jbm.a.35074. Epub 2014 Jan 6.

PMID:
24376053
44.

Damnacanthal: a promising compound as a medicinal anthraquinone.

Abu N, Ali NM, Ho WY, Yeap SK, Aziz MY, Alitheen NB.

Anticancer Agents Med Chem. 2014 Jun;14(5):750-5. Review.

PMID:
24164045
45.

The flavokawains: uprising medicinal chalcones.

Abu N, Ho WY, Yeap SK, Akhtar MN, Abdullah MP, Omar AR, Alitheen NB.

Cancer Cell Int. 2013 Oct 22;13(1):102. doi: 10.1186/1475-2867-13-102.

46.

3-Bromo-1-hydroxy-9,10-anthraquinone (BHAQ) inhibits growth and migration of the human breast cancer cell lines MCF-7 and MDA-MB231.

Abu N, Akhtar MN, Ho WY, Yeap SK, Alitheen NB.

Molecules. 2013 Aug 27;18(9):10367-77. doi: 10.3390/molecules180910367.

47.

Identification and characterization of CHCHD1, AURKAIP1, and CRIF1 as new members of the mammalian mitochondrial ribosome.

Koc EC, Cimen H, Kumcuoglu B, Abu N, Akpinar G, Haque ME, Spremulli LL, Koc H.

Front Physiol. 2013 Jul 30;4:183. doi: 10.3389/fphys.2013.00183. eCollection 2013.

49.

A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.

Meirik O, Brache V, Orawan K, Habib NA, Schmidt J, Ortayli N, Culwell K, Jackson E, Ali M; WHO Study Group on Contraceptive Implants for Women.

Contraception. 2013 Jan;87(1):113-20. doi: 10.1016/j.contraception.2012.08.044. Epub 2012 Oct 10.

PMID:
23063337

Supplemental Content

Loading ...
Support Center